![]()
|
|
||||||||
(Received for publication, July 17, 1997, and in revised form, September 19, 1997)
From the Development of colon cancer is a multistep
process frequently involving mutations in both the
APC and p53 tumor suppressor genes. In
this study we treated the HCT-116 colon cancer cell line with
alkylating agents including
N-methyl-N
Volume 272, Number 49,
Issue of December 5, 1997
pp. 30619-30622
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
COMMUNICATION:
Activation of Adenomatous Polyposis Coli (APC) Gene
Expression by the DNA-alkylating Agent
N-MethylN
-nitro-N-nitrosoguanidine
Requires p53
§
and
Sealy Center for Oncology and Hematology and
§ Department of Human Biological Chemistry and Genetics,
University of Texas Medical Branch, Galveston, Texas 77555-1048
-nitro-N-nitrosoguanidine (MNNG),which is known to cause colon cancer in animals, and
examined the expression of both APC and p53
genes. Exposure of cells with MNNG caused an 8-12-fold increase in the
level of APC mRNA and protein. APC induction was shown
to result from increased nuclear transcription of the APC
gene and correlated with a concomitant increase in the p53 protein
level after MNNG treatment. A necessary role for p53 in APC
gene regulation is supported by the failure of MNNG to induce
APC expression in cell lines either expressing very low
levels of p53 (HeLa cells) or no p53 (K562 erythroleukemia cells). The
overexpression of wild-type p53 gene into HCT-116 cells
mimicked the effect of MNNG-induced expression of APC
mRNA. A direct causal role for p53 in APC gene
regulation was further evaluated by transfecting the wild-type
p53 gene into K562 cells and observing a 5-fold increase in
the APC gene expression. These results support a model
featuring a direct link between p53 and APC in response to
alkylation-induced DNA damage and suggest a novel role for p53 in a
stress-response pathway involving APC.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. N. Kundu, R. Balusu, A. S. Jaiswal, and S. Narayan Adenomatous polyposis coli-mediated hypersensitivity of mouse embryonic fibroblast cell lines to methylmethane sulfonate treatment: implication of base excision repair pathways Carcinogenesis, October 1, 2007; 28(10): 2089 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jaiswal, R. Balusu, and S. Narayan 7,12-Dimethylbenzanthracene-dependent transcriptional regulation of adenomatous polyposis coli (APC) gene expression in normal breast epithelial cells is mediated by GC-box binding protein Sp3 Carcinogenesis, February 1, 2006; 27(2): 252 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Narayan, A. S. Jaiswal, and R. Balusu Tumor Suppressor APC Blocks DNA Polymerase {beta}-dependent Strand Displacement Synthesis during Long Patch but Not Short Patch Base Excision Repair and Increases Sensitivity to Methylmethane Sulfonate J. Biol. Chem., February 25, 2005; 280(8): 6942 - 6949. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Ahn and J. J. Schroeder Sphingoid Bases and Ceramide Induce Apoptosis in HT-29 and HCT-116 Human Colon Cancer Cells Experimental Biology and Medicine, May 1, 2002; 227(5): 345 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Homma, D. Li, E. G. Krebs, Y. Yuasa, and Y. Homma Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein PNAS, April 30, 2002; 99(9): 5959 - 5964. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sadot, B. Geiger, M. Oren, and A. Ben-Ze'ev Down-Regulation of {beta}-Catenin by Activated p53 Mol. Cell. Biol., October 15, 2001; 21(20): 6768 - 6781. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parra, F. Lluis, F. Miralles, C. Caelles, and P. Munoz-Canoves The cJun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (uPA) by the alkylating agent MNNG Blood, August 15, 2000; 96(4): 1415 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jaiswal and S. Narayan p53-dependent Transcriptional Regulation of the APC Promoter in Colon Cancer Cells Treated with DNA Alkylating Agents J. Biol. Chem., May 18, 2001; 276(21): 18193 - 18199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parra, M. Jardi, M. Koziczak, Y. Nagamine, and P. Munoz-Canoves p53 Phosphorylation at Serine 15 Is Required for Transcriptional Induction of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene by the Alkylating Agent N-Methyl-N'-nitro-N-nitrosoguanidine J. Biol. Chem., September 21, 2001; 276(39): 36303 - 36310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Halberg, D. S. Katzung, P. D. Hoff, A. R. Moser, C. E. Cole, R. A. Lubet, L. A. Donehower, R. F. Jacoby, and W. F. Dove Tumorigenesis in the multiple intestinal neoplasia mouse: Redundancy of negative regulators and specificity of modifiers PNAS, March 28, 2000; 97(7): 3461 - 3466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Homma, D. Li, E. G. Krebs, Y. Yuasa, and Y. Homma Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein PNAS, April 30, 2002; 99(9): 5959 - 5964. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |